These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
241 related items for PubMed ID: 32578507
21. Cadherin expression pattern in melanocytic tumors more likely depends on the melanocyte environment than on tumor cell progression. Krengel S, Grotelüschen F, Bartsch S, Tronnier M. J Cutan Pathol; 2004 Jan; 31(1):1-7. PubMed ID: 14675278 [Abstract] [Full Text] [Related]
22. Review of the comparative pathological and immunohistochemical features of human and canine cutaneous melanocytic neoplasms. Contel IJ, Fonseca-Alves CE, Ferrari HF, Laufer-Amorim R, Xavier-Júnior JCC. J Comp Pathol; 2024 May; 211():26-35. PubMed ID: 38761560 [Abstract] [Full Text] [Related]
23. A comparative review of melanocytic neoplasms. Smith SH, Goldschmidt MH, McManus PM. Vet Pathol; 2002 Nov; 39(6):651-78. PubMed ID: 12450197 [Abstract] [Full Text] [Related]
24. Canine cutaneous melanocytic tumours: significance of β-catenin and survivin immunohistochemical expression. Bongiovanni L, D'Andrea A, Porcellato I, Ciccarelli A, Malatesta D, Romanucci M, Della Salda L, Mechelli L, Brachelente C. Vet Dermatol; 2015 Aug; 26(4):270-e59. PubMed ID: 25962968 [Abstract] [Full Text] [Related]
25. E-cadherin in canine mast cell tumors: decreased expression and altered subcellular localization in Grade 3 tumors. Mackowiak II, Gentile LB, Chaible LM, Nagamine MK, Guerra JM, Mota EF, Matera JM, Mennecier G, Sanches DS, Dagli ML. Vet J; 2012 Dec; 194(3):405-11. PubMed ID: 22766308 [Abstract] [Full Text] [Related]
26. SOX-10 and TRP-1 expression in feline ocular and nonocular melanomas. Orlandi M, Porcellato I, Sforna M, Lo Giudice A, Giglia G, Mechelli L, Brachelente C. Vet Pathol; 2024 Sep; 61(5):712-720. PubMed ID: 38613415 [Abstract] [Full Text] [Related]
27. Antigen expression in canine tissues, recognized by a monoclonal antibody generated against canine melanoma cells. Oliver JL, Wolfe LG. Am J Vet Res; 1992 Jan; 53(1):123-8. PubMed ID: 1539903 [Abstract] [Full Text] [Related]
28. FoxP3, CTLA-4, and IDO in Canine Melanocytic Tumors. Porcellato I, Brachelente C, Cappelli K, Menchetti L, Silvestri S, Sforna M, Mecocci S, Iussich S, Leonardi L, Mechelli L. Vet Pathol; 2021 Jan; 58(1):42-52. PubMed ID: 33021155 [Abstract] [Full Text] [Related]
29. Characteristics of canine melanomas and comparison of histology and DNA ploidy to their biologic behavior. Bolon B, Calderwood Mays MB, Hall BJ. Vet Pathol; 1990 Mar; 27(2):96-102. PubMed ID: 2345943 [Abstract] [Full Text] [Related]
30. Canine balloon and signet-ring cell melanomas: a histological and immunohistochemical characterization. Cangul IT, van Garderen E, van der Linde-Sipman JS, van den Ingh TS, Schalken JA. J Comp Pathol; 2001 Mar; 125(2-3):166-73. PubMed ID: 11578133 [Abstract] [Full Text] [Related]
31. Immunohistochemical investigation of PNL2 reactivity of canine melanocytic neoplasms and comparison with Melan A. Giudice C, Ceciliani F, Rondena M, Stefanello D, Grieco V. J Vet Diagn Invest; 2010 May; 22(3):389-94. PubMed ID: 20453212 [Abstract] [Full Text] [Related]
32. Cyclooxygenase-2 expression is related with localization, proliferation, and overall survival in canine melanocytic neoplasms. Martínez CM, Peñafiel-Verdú C, Vilafranca M, Ramírez G, Méndez-Gallego M, Buendía AJ, Sánchez J. Vet Pathol; 2011 Nov; 48(6):1204-11. PubMed ID: 21292918 [Abstract] [Full Text] [Related]
33. Tumour-infiltrating lymphocytes in canine melanocytic tumours: An investigation on the prognostic role of CD3+ and CD20+ lymphocytic populations. Porcellato I, Silvestri S, Menchetti L, Recupero F, Mechelli L, Sforna M, Iussich S, Bongiovanni L, Lepri E, Brachelente C. Vet Comp Oncol; 2020 Sep; 18(3):370-380. PubMed ID: 31750993 [Abstract] [Full Text] [Related]
34. Immunohistochemical expression of MDR1-Pgp 170 in canine cutaneous and oral melanomas: pattern of expression and association with tumour location and phenotype. Finotello R, Monné Rodriguez JM, Vilafranca M, Altimira J, Ramirez GA, Haines A, Ressel L. Vet Comp Oncol; 2017 Dec; 15(4):1393-1402. PubMed ID: 27779366 [Abstract] [Full Text] [Related]
35. Comparison of tyrosinase-related protein-2, S-100, and Melan A immunoreactivity in canine amelanotic melanomas. Choi C, Kusewitt DF. Vet Pathol; 2003 Nov; 40(6):713-8. PubMed ID: 14608029 [Abstract] [Full Text] [Related]
36. Immunohistochemical characterization and evaluation of prognostic factors in canine oral melanomas with osteocartilaginous differentiation. Sánchez J, Ramirez GA, Buendia AJ, Vilafranca M, Martinez CM, Altimira J, Navarro JA. Vet Pathol; 2007 Sep; 44(5):676-82. PubMed ID: 17846240 [Abstract] [Full Text] [Related]
37. BRAF and epithelial-mesenchymal transition in primary cutaneous melanoma: a role for Snail and E-cadherin? Mitchell B, Leone DA, Feller JK, Yang S, Mahalingam M. Hum Pathol; 2016 Jun; 52():19-27. PubMed ID: 26980024 [Abstract] [Full Text] [Related]
38. Immunohistochemical detection of melanoma-associated antigens on formalin-fixed, paraffin-embedded canine tumors. Berrington AJ, Jimbow K, Haines DM. Vet Pathol; 1994 Jul; 31(4):455-61. PubMed ID: 7941235 [Abstract] [Full Text] [Related]
39. Cutaneous malignant melanomas in 57 cats: identification of (amelanotic) signet-ring and balloon cell types and verification of their origin by immunohistochemistry, electron microscopy, and in situ hybridization. van der Linde-Sipman JS, de Wit MM, van Garderen E, Molenbeek RF, van der Velde-Zimmermann D, de Weger RA. Vet Pathol; 1997 Jan; 34(1):31-8. PubMed ID: 9150543 [Abstract] [Full Text] [Related]
40. Retrospective study of 338 canine oral melanomas with clinical, histologic, and immunohistochemical review of 129 cases. Ramos-Vara JA, Beissenherz ME, Miller MA, Johnson GC, Pace LW, Fard A, Kottler SJ. Vet Pathol; 2000 Nov; 37(6):597-608. PubMed ID: 11105949 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]